Recombinant Human Serum Albumin Market

Future Market Insights

Key Insight

The recombinant human serum albumin market is projected to grow from USD 117.9 million in 2025 to USD 320.1 million by 2035, at a CAGR of 10.5%. Yeast expression system will dominate with a 40.3% market share, while biopharmaceuticals will lead the application segment with a 70.0% share.

September 26, 2025

Anurag Sharma

250 Pages

Cite this Report

Recombinant Human Serum Albumin Market

https://www.futuremarketinsights.com/reports/recombinant-human-serum-albumin-market

License

Buy Now

Summary ToC Companies

Key Players

ACROBiosystems
Abcam plc
Assay Genie Ltd
Basic Pharma
Cell Biologics
InVitria
MP Biomedicals LLC
MedChemexpress LLC
Merck KGaA
Proteintech Group
Reprokine
Sartorius AG
Sino Biological,Inc
Yeasen

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Recombinant Human Serum Albumin Market

Key Players

Similar Industry Reports